Skip to content
CHERESO
CHERESO
Search:
Any Query?
info@chereso.net
  • Home
  • COMPANY
    • ABOUT US
    • VISION & MISSION
    • AWARDS & ACCREDITATIONS
    • SOCIAL RESPONSIBILITY
    • CAREER OPPORTUNITIES
  • ACTIVE INGREDIENTS
  • BRANDED INGREDIENTS
  • MANUFACTURING
    • OUR STATE OF ART FACILITIES
    • QUALITY CONTROL
    • RESEARCH & DEVELOPMENT
  • NEWS & EVENTS
    • NEWS
    • INTERNATIONAL NEWS
    • EVENTS
    • PRESENTATIONS
  • CONTACT US
  • Home
  • COMPANY
    • ABOUT US
    • VISION & MISSION
    • AWARDS & ACCREDITATIONS
    • SOCIAL RESPONSIBILITY
    • CAREER OPPORTUNITIES
  • ACTIVE INGREDIENTS
  • BRANDED INGREDIENTS
  • MANUFACTURING
    • OUR STATE OF ART FACILITIES
    • QUALITY CONTROL
    • RESEARCH & DEVELOPMENT
  • NEWS & EVENTS
    • NEWS
    • INTERNATIONAL NEWS
    • EVENTS
    • PRESENTATIONS
  • CONTACT US

Events

You are here:
  1. Home
  2. Events

TEAM FENFURO had participated in UPDACON-annual congress of Uttar Pradesh Diabetes Association which was held on 17 & 18 November 2012 at Scientific Convention Center, CSMMU ,Lucknow, the state capital of Uttar Pradesh which happens to be highest populated state of India. The conference was attended by more than 600 physicians and endocrinologists who put their idea to fight with Diabetes and create awareness among people for the prevention of diabetes and they have also promoted life style modifications as well as motivated people for early detection and treatment and to avoid late life threatening complications of Diabetes. It was the endeavor to update physicians and general practitioners about newer modalities of diagnosis and treatment.

Details

Participated in 11th annual congress of Uttar Pradesh Diabetes Associations

Details

Diabetes Drug May Affect Thyroid in Some Patients

Details

Taking Insulin for T2 Diabetes Could Expose Patients to Greater Risk of Health Complications

Details

Abstract Submission: “Clinical Evaluation Of Standardized Fenugreek Seed Extract As Furostanolic Saponins (Furocyst) In Polycystic Ovary Syndome Patients.”

Details

Abstract Submission: “Clinical Evaluation Fenugreek Seed Extract In Patients With Type-2 Diabetes: An Add-on Study In 154 Patients”

Details

Abstract Submission: Safety, Efficacy And Toxicological Evaluation Of A Novel, Patented Anti-diabetic Extract Of Trigonella Foenum-graecum Seed Extract (Fenfuro)

Details

Abstract submission: “Efficacy of a novel fenugreek seed extract (trigonella foenum-graecum, furocyst) in polycystic ovary syndrome (pcos)”

Details

Abstract submission: ” Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of trigonella foenum-graecum seed extract (fenfuro).”

Details

Abstract Submission: Safety, efficacy and toxicological evaluation of a novel, patented anti-diabetic extract of Trigonella Foenum-Graecum seed extract (Fenfuro)

Details
←1
234567891011
…1213141516…
1718
19→
QUICK LINKS
Home
About Us
Awards & Accreditations
Vision & Mission
Certificates
Products
Manufacturing
Career Opportunities
NEWSLETTER

    DISCLAIMER

    Information on this website has been posted in public interest for creating awareness about diabetes/obesity/general health. In event of any copyright conflicts, please inform so that we may take appropriate remedial measures. The products and the claims made on this site have not been evaluated by FDA and are not approved to diagnose, treat, cure or prevent diseases. This website is for indian market only.

    WE SUPPORT
    2440375
    Total Visitors
    Copyright @ 2014 - Chemical Resources

    Site by SWS

    Go to Top

      • →
      • Contact Us